Erratum to: A multicenter, open-label, dose-ranging study to exploratively evaluate the efficacy, safety, and dose–response of tolvaptan in patients with decompensated liver cirrhosis | Zendy

AI Assistant Blog Pricing

Erratum to: A multicenter, open-label, dose-ranging study to exploratively evaluate the efficacy, safety, and dose–response of tolvaptan in patients with decompensated liver cirrhosis

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.